Innovation through the Adoption and Strategic Use of Advanced Technologies
First written in FY2016. 24 of 31 entries say "Restated". Latest entry: 2026-07-29.
The whole theme swung hardest in 2024: 4 of 30 companies on the "Worse" side.
27 other companies' latest entry also says "Advanced".
- 2026-07-29AdvancedEarnings presentation
「医療・介護分野に向けて高付加価値 AIツールの開発と市場投入を推進。」
先端技術の活用方針が、医療・介護分野のAIツールの開発・市場投入という具体的な施策に進んでいる。 - FY2026AdvancedAnnual report
「The total R&D expenses incurred by the Group during the consolidated fiscal year were ¥327 million.」
R&D expenses increased to ¥327 million from ¥265 million in the previous fiscal year. R&D themes have also become more specific, including public services, healthcare, generative AI, digital transformation in manufacturing and space technology. - FY2026-H1RestatedAnnual report
「Total R&D expenses for the interim consolidated accounting period were ¥169 million (¥107 million for the Future Society Solutions Business and ¥62 million for the Industrial Technology Solutions Business). There were no material changes in the status of the Group's R&D activities during the interim consolidated accounting period.」
The company continues to invest in R&D and has disclosed total R&D expenses of ¥169 million. It also states that there have been no material changes in the status of its R&D activities. - FY2025-H1RestatedAnnual report
「Total R&D expenses for the interim consolidated accounting period were ¥144 million (¥86 million for the Future Society Solutions Business and ¥58 million for the Industrial Technology Solutions Business). There were no material changes in the status of the Group's R&D activities during the interim consolidated accounting period.」
The company continues to invest in R&D, with R&D expenses disclosed at ¥144 million, while stating that there have been no material changes in the status of its R&D activities. - FY2024AdvancedAnnual report
「The total R&D expenses incurred by the Group during the consolidated fiscal year were ¥265 million.」
The company continues to pursue innovation through the introduction and strategic use of advanced technologies. R&D expenses were ¥265 million, comprising ¥164 million for the Future Society Solutions Business and ¥101 million for the Industrial Technology Solutions Business. - FY2024-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter were ¥188 million (¥108 million for the Future Society Solutions Business and ¥80 million for the Industrial Technology Solutions Business). There were no material changes in the status of the Group's R&D activities during the cumulative third quarter.」
The company continues to invest in R&D and has recorded cumulative R&D expenses of ¥188 million, while stating that there have been no material changes in the status of its R&D activities. - FY2024-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter were ¥128 million (¥66 million for the Future Society Solutions Business and ¥61 million for the Industrial Technology Solutions Business). There were no material changes in the status of the Group's R&D activities during the cumulative second quarter.」
The company continues to invest in R&D, while stating that there have been no material changes in the status of its R&D activities. - FY2023-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter were ¥175 million for the Solutions Business. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter.」
The company continues to invest in R&D for the Solutions Business. It states that there have been no material changes in the status of its R&D activities, and no progress to a new stage, such as completion of a specific technology or product commercialization, has been disclosed. - FY2023-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter were ¥126 million for the Solutions Business.」
The company continues to invest in R&D in the Solutions Business. No progress to a new stage, such as completion of a specific technology or product commercialization, has been disclosed. - FY2023-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter were ¥66 million for the Solutions Business. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter.」
The company continues to invest in R&D for the Solutions Business, while stating that there have been no material changes in its R&D activities. - FY2022RestatedAnnual report
「The results of our research are being incorporated into products and commercialized within the Group, as well as into collaborations with other companies.」
The Group continues to pursue innovation through the introduction and strategic use of advanced technologies, and to incorporate research results into products and collaborations. R&D expenses were ¥226 million. - FY2022-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter were ¥144 million in the solutions business. There were no material changes in the status of our group’s R&D activities during the cumulative third quarter.」
R&D investment in the solutions business is continuing, with R&D expenses reaching ¥144 million. It states that there were no material changes in the status of R&D activities. - FY2022-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter were ¥79 million in the solutions business.」
R&D investment in the solutions business is continuing. No new milestone, such as completion or commercialization of a specific technology, is described. - FY2022-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter were ¥40 million in the solutions business. There were no material changes in the status of our group’s R&D activities during the cumulative first quarter.」
The solutions business recorded R&D expenses of ¥40 million and states that there were no material changes in the status of R&D activities. - FY2021AdvancedAnnual report
「Our group is focusing on adopting and strategically utilizing advanced technologies in order to anticipate markets in modern society, which is undergoing major changes, through innovation based on advanced science and technology. Research results are incorporated into our group’s products and commercialization efforts, as well as collaborations with other companies.」
The policy of innovation through the adoption and strategic use of advanced technologies is continuing, and R&D expenses increased to ¥307 million from ¥287 million in the previous year. - FY2021-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter were ¥226 million in the solutions business. There were no material changes in the status of our group’s R&D activities during the cumulative third quarter.」
R&D investment in the solutions business is continuing. No material changes in R&D activities or completion or commercialization of a specific technology are described. - FY2021-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter were ¥176 million in the solutions business.」
R&D investment in the solutions business is continuing. No specific product completion or R&D milestone is described. - FY2021-Q1AdvancedAnnual report
「Total R&D expenses for the cumulative first quarter were ¥80 million in the solutions business.」
R&D expenses in the solutions business were ¥80 million, up from ¥62 million in the same period of the previous year. - FY2020RestatedAnnual report
「Our group is focusing on adopting and strategically utilizing advanced technologies in order to anticipate markets in modern society, which is undergoing major changes, through innovation based on advanced science and technology.」
The policy of innovation through the adoption and strategic use of advanced technologies is continuing. R&D expenses were ¥287 million. - FY2020-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter were ¥196 million in the solutions business.」
R&D investment in the solutions business is continuing. No new achievements, such as completion or commercialization of a specific technology, are described. - FY2020-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter were ¥116 million in the solutions business.」
R&D investment in the solutions business is continuing. - FY2020-Q1AdvancedAnnual report
「Total R&D expenses for the cumulative first quarter were ¥62 million in the solutions business.」
R&D investment in the solutions business is continuing, with R&D expenses increasing from ¥57 million in the same period of the previous year to ¥62 million. - FY2019RestatedAnnual report
「Our group is focusing on adopting and strategically utilizing advanced technologies in order to anticipate markets in modern society, which is undergoing major changes, through innovation based on advanced science and technology.」
The policy of innovation through the adoption and strategic use of advanced technologies is continuing. R&D expenses are stated as ¥286 million. - FY2019-Q2RestatedAnnual report
「In the core business, a proposal-based solution business, the Company is focusing on creating new products and solutions through research and development investment, including in GNSS and media,」
The policy of continuing R&D investment using advanced technologies and creating new products and solutions is continuing. Total R&D expenses in the solutions business are stated as ¥128 million. - FY2019-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter were ¥57 million in the solutions business.」
R&D investment in the solutions business is continuing, with total R&D expenses for the first quarter stated as ¥57 million. - FY2018RestatedAnnual report
「Our group is focusing on adopting and strategically utilizing advanced technologies in order to anticipate markets in modern society, which is undergoing major changes, through innovation based on advanced science and technology.」
The policy of innovation through the adoption and strategic use of advanced technologies is continuing. R&D expenses are stated as ¥271 million, but no completion of a specific technology or achievement of commercialization is indicated. - FY2018-Q3RestatedAnnual report
「We will accelerate investment in our proprietary specialized technologies, including GNSS (Global Navigation Satellite System) and media solutions.」
It reiterates the policy of accelerating investment in proprietary specialized technologies, including GNSS and media solutions. - FY2018-Q2RestatedAnnual report
「We will accelerate investment in our proprietary specialized technologies, including GNSS (Global Navigation Satellite System) and media solutions.」
It reiterates the policy of accelerating investment in proprietary specialized technologies, including GNSS and media solutions. - FY2018-Q1RestatedAnnual report
「We will accelerate investment in our proprietary specialized technologies, including GNSS (Global Navigation Satellite System) and media solutions.」
The policy of advancing the rollout of solutions through investment in proprietary specialized technologies is continuing. - FY2017RestatedAnnual report
「Our group is focusing on adopting and strategically utilizing advanced technologies in order to anticipate markets in modern society, which is undergoing major changes, through innovation based on advanced science and technology.」
The policy of innovation through the adoption and strategic use of advanced technologies is reiterated in the group’s research and development activities. - FY2016First statedAnnual report
「Our group is focusing on adopting and strategically utilizing advanced technologies in order to anticipate markets in modern society, which is undergoing major changes, through innovation based on advanced science and technology.」
It demonstrates a research and development approach of adopting and strategically utilizing advanced technologies to anticipate market changes.